Global Subcutaneous Vaccine Adjuvants Supply, Demand and Key Producers, 2024-2030

Page: 142

Published Date: 10 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Subcutaneous Vaccine Adjuvants market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Subcutaneous Vaccine Adjuvants is used for Subcutaneous injection of Vaccine Adjuvants. A vaccine adjuvant is any material which is incorporated with a vaccine for the purpose of enhancing the immune response of the vaccine. An adjuvanted vaccine will tend to have a higher, earlier, and longer-lasting immune response than a non-adjuvanted vaccine.

This report studies the global Subcutaneous Vaccine Adjuvants production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Subcutaneous Vaccine Adjuvants, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Subcutaneous Vaccine Adjuvants that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Subcutaneous Vaccine Adjuvants total production and demand, 2019-2030, (K Units)
Global Subcutaneous Vaccine Adjuvants total production value, 2019-2030, (USD Million)
Global Subcutaneous Vaccine Adjuvants production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Subcutaneous Vaccine Adjuvants consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Subcutaneous Vaccine Adjuvants domestic production, consumption, key domestic manufacturers and share
Global Subcutaneous Vaccine Adjuvants production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Subcutaneous Vaccine Adjuvants production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Subcutaneous Vaccine Adjuvants production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).

This reports profiles key players in the global Subcutaneous Vaccine Adjuvants market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health, Associated British Foods, InvivoGen, Merck KGaA and CSL Limited, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Subcutaneous Vaccine Adjuvants market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Subcutaneous Vaccine Adjuvants Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Subcutaneous Vaccine Adjuvants Market, Segmentation by Type
Infectious Diseases
Cancer
Others

Global Subcutaneous Vaccine Adjuvants Market, Segmentation by Application
Research Applications
Commercial Applications

Companies Profiled:
Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
GSK
Dynavax Technologies
Novavax

Key Questions Answered
1. How big is the global Subcutaneous Vaccine Adjuvants market?
2. What is the demand of the global Subcutaneous Vaccine Adjuvants market?
3. What is the year over year growth of the global Subcutaneous Vaccine Adjuvants market?
4. What is the production and production value of the global Subcutaneous Vaccine Adjuvants market?
5. Who are the key producers in the global Subcutaneous Vaccine Adjuvants market?

Table of Contents

1 Supply Summary
    1.1 Subcutaneous Vaccine Adjuvants Introduction
    1.2 World Subcutaneous Vaccine Adjuvants Supply & Forecast
        1.2.1 World Subcutaneous Vaccine Adjuvants Production Value (2019 & 2023 & 2030)
        1.2.2 World Subcutaneous Vaccine Adjuvants Production (2019-2030)
        1.2.3 World Subcutaneous Vaccine Adjuvants Pricing Trends (2019-2030)
    1.3 World Subcutaneous Vaccine Adjuvants Production by Region (Based on Production Site)
        1.3.1 World Subcutaneous Vaccine Adjuvants Production Value by Region (2019-2030)
        1.3.2 World Subcutaneous Vaccine Adjuvants Production by Region (2019-2030)
        1.3.3 World Subcutaneous Vaccine Adjuvants Average Price by Region (2019-2030)
        1.3.4 North America Subcutaneous Vaccine Adjuvants Production (2019-2030)
        1.3.5 Europe Subcutaneous Vaccine Adjuvants Production (2019-2030)
        1.3.6 China Subcutaneous Vaccine Adjuvants Production (2019-2030)
        1.3.7 Japan Subcutaneous Vaccine Adjuvants Production (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Subcutaneous Vaccine Adjuvants Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Subcutaneous Vaccine Adjuvants Major Market Trends

2 Demand Summary
    2.1 World Subcutaneous Vaccine Adjuvants Demand (2019-2030)
    2.2 World Subcutaneous Vaccine Adjuvants Consumption by Region
        2.2.1 World Subcutaneous Vaccine Adjuvants Consumption by Region (2019-2024)
        2.2.2 World Subcutaneous Vaccine Adjuvants Consumption Forecast by Region (2025-2030)
    2.3 United States Subcutaneous Vaccine Adjuvants Consumption (2019-2030)
    2.4 China Subcutaneous Vaccine Adjuvants Consumption (2019-2030)
    2.5 Europe Subcutaneous Vaccine Adjuvants Consumption (2019-2030)
    2.6 Japan Subcutaneous Vaccine Adjuvants Consumption (2019-2030)
    2.7 South Korea Subcutaneous Vaccine Adjuvants Consumption (2019-2030)
    2.8 ASEAN Subcutaneous Vaccine Adjuvants Consumption (2019-2030)
    2.9 India Subcutaneous Vaccine Adjuvants Consumption (2019-2030)

3 World Subcutaneous Vaccine Adjuvants Manufacturers Competitive Analysis
    3.1 World Subcutaneous Vaccine Adjuvants Production Value by Manufacturer (2019-2024)
    3.2 World Subcutaneous Vaccine Adjuvants Production by Manufacturer (2019-2024)
    3.3 World Subcutaneous Vaccine Adjuvants Average Price by Manufacturer (2019-2024)
    3.4 Subcutaneous Vaccine Adjuvants Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Subcutaneous Vaccine Adjuvants Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Subcutaneous Vaccine Adjuvants in 2023
        3.5.3 Global Concentration Ratios (CR8) for Subcutaneous Vaccine Adjuvants in 2023
    3.6 Subcutaneous Vaccine Adjuvants Market: Overall Company Footprint Analysis
        3.6.1 Subcutaneous Vaccine Adjuvants Market: Region Footprint
        3.6.2 Subcutaneous Vaccine Adjuvants Market: Company Product Type Footprint
        3.6.3 Subcutaneous Vaccine Adjuvants Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Subcutaneous Vaccine Adjuvants Production Value Comparison
        4.1.1 United States VS China: Subcutaneous Vaccine Adjuvants Production Value Comparison (2019 & 2023 & 2030)
        4.1.2 United States VS China: Subcutaneous Vaccine Adjuvants Production Value Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States VS China: Subcutaneous Vaccine Adjuvants Production Comparison
        4.2.1 United States VS China: Subcutaneous Vaccine Adjuvants Production Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Subcutaneous Vaccine Adjuvants Production Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States VS China: Subcutaneous Vaccine Adjuvants Consumption Comparison
        4.3.1 United States VS China: Subcutaneous Vaccine Adjuvants Consumption Comparison (2019 & 2023 & 2030)
        4.3.2 United States VS China: Subcutaneous Vaccine Adjuvants Consumption Market Share Comparison (2019 & 2023 & 2030)
    4.4 United States Based Subcutaneous Vaccine Adjuvants Manufacturers and Market Share, 2019-2024
        4.4.1 United States Based Subcutaneous Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Subcutaneous Vaccine Adjuvants Production Value (2019-2024)
        4.4.3 United States Based Manufacturers Subcutaneous Vaccine Adjuvants Production (2019-2024)
    4.5 China Based Subcutaneous Vaccine Adjuvants Manufacturers and Market Share
        4.5.1 China Based Subcutaneous Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Subcutaneous Vaccine Adjuvants Production Value (2019-2024)
        4.5.3 China Based Manufacturers Subcutaneous Vaccine Adjuvants Production (2019-2024)
    4.6 Rest of World Based Subcutaneous Vaccine Adjuvants Manufacturers and Market Share, 2019-2024
        4.6.1 Rest of World Based Subcutaneous Vaccine Adjuvants Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Subcutaneous Vaccine Adjuvants Production Value (2019-2024)
        4.6.3 Rest of World Based Manufacturers Subcutaneous Vaccine Adjuvants Production (2019-2024)

5 Market Analysis by Type
    5.1 World Subcutaneous Vaccine Adjuvants Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Infectious Diseases
        5.2.2 Cancer
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Subcutaneous Vaccine Adjuvants Production by Type (2019-2030)
        5.3.2 World Subcutaneous Vaccine Adjuvants Production Value by Type (2019-2030)
        5.3.3 World Subcutaneous Vaccine Adjuvants Average Price by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Subcutaneous Vaccine Adjuvants Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Research Applications
        6.2.2 Commercial Applications
    6.3 Market Segment by Application
        6.3.1 World Subcutaneous Vaccine Adjuvants Production by Application (2019-2030)
        6.3.2 World Subcutaneous Vaccine Adjuvants Production Value by Application (2019-2030)
        6.3.3 World Subcutaneous Vaccine Adjuvants Average Price by Application (2019-2030)

7 Company Profiles
    7.1 Agenus
        7.1.1 Agenus Details
        7.1.2 Agenus Major Business
        7.1.3 Agenus Subcutaneous Vaccine Adjuvants Product and Services
        7.1.4 Agenus Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.1.5 Agenus Recent Developments/Updates
        7.1.6 Agenus Competitive Strengths & Weaknesses
    7.2 Croda International
        7.2.1 Croda International Details
        7.2.2 Croda International Major Business
        7.2.3 Croda International Subcutaneous Vaccine Adjuvants Product and Services
        7.2.4 Croda International Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.2.5 Croda International Recent Developments/Updates
        7.2.6 Croda International Competitive Strengths & Weaknesses
    7.3 Seppic
        7.3.1 Seppic Details
        7.3.2 Seppic Major Business
        7.3.3 Seppic Subcutaneous Vaccine Adjuvants Product and Services
        7.3.4 Seppic Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.3.5 Seppic Recent Developments/Updates
        7.3.6 Seppic Competitive Strengths & Weaknesses
    7.4 OZ Biosciences
        7.4.1 OZ Biosciences Details
        7.4.2 OZ Biosciences Major Business
        7.4.3 OZ Biosciences Subcutaneous Vaccine Adjuvants Product and Services
        7.4.4 OZ Biosciences Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.4.5 OZ Biosciences Recent Developments/Updates
        7.4.6 OZ Biosciences Competitive Strengths & Weaknesses
    7.5 Phibro Animal Health
        7.5.1 Phibro Animal Health Details
        7.5.2 Phibro Animal Health Major Business
        7.5.3 Phibro Animal Health Subcutaneous Vaccine Adjuvants Product and Services
        7.5.4 Phibro Animal Health Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.5.5 Phibro Animal Health Recent Developments/Updates
        7.5.6 Phibro Animal Health Competitive Strengths & Weaknesses
    7.6 Associated British Foods
        7.6.1 Associated British Foods Details
        7.6.2 Associated British Foods Major Business
        7.6.3 Associated British Foods Subcutaneous Vaccine Adjuvants Product and Services
        7.6.4 Associated British Foods Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.6.5 Associated British Foods Recent Developments/Updates
        7.6.6 Associated British Foods Competitive Strengths & Weaknesses
    7.7 InvivoGen
        7.7.1 InvivoGen Details
        7.7.2 InvivoGen Major Business
        7.7.3 InvivoGen Subcutaneous Vaccine Adjuvants Product and Services
        7.7.4 InvivoGen Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.7.5 InvivoGen Recent Developments/Updates
        7.7.6 InvivoGen Competitive Strengths & Weaknesses
    7.8 Merck KGaA
        7.8.1 Merck KGaA Details
        7.8.2 Merck KGaA Major Business
        7.8.3 Merck KGaA Subcutaneous Vaccine Adjuvants Product and Services
        7.8.4 Merck KGaA Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.8.5 Merck KGaA Recent Developments/Updates
        7.8.6 Merck KGaA Competitive Strengths & Weaknesses
    7.9 CSL Limited
        7.9.1 CSL Limited Details
        7.9.2 CSL Limited Major Business
        7.9.3 CSL Limited Subcutaneous Vaccine Adjuvants Product and Services
        7.9.4 CSL Limited Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.9.5 CSL Limited Recent Developments/Updates
        7.9.6 CSL Limited Competitive Strengths & Weaknesses
    7.10 GSK
        7.10.1 GSK Details
        7.10.2 GSK Major Business
        7.10.3 GSK Subcutaneous Vaccine Adjuvants Product and Services
        7.10.4 GSK Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.10.5 GSK Recent Developments/Updates
        7.10.6 GSK Competitive Strengths & Weaknesses
    7.11 Dynavax Technologies
        7.11.1 Dynavax Technologies Details
        7.11.2 Dynavax Technologies Major Business
        7.11.3 Dynavax Technologies Subcutaneous Vaccine Adjuvants Product and Services
        7.11.4 Dynavax Technologies Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.11.5 Dynavax Technologies Recent Developments/Updates
        7.11.6 Dynavax Technologies Competitive Strengths & Weaknesses
    7.12 Novavax
        7.12.1 Novavax Details
        7.12.2 Novavax Major Business
        7.12.3 Novavax Subcutaneous Vaccine Adjuvants Product and Services
        7.12.4 Novavax Subcutaneous Vaccine Adjuvants Production, Price, Value, Gross Margin and Market Share (2019-2024)
        7.12.5 Novavax Recent Developments/Updates
        7.12.6 Novavax Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Subcutaneous Vaccine Adjuvants Industry Chain
    8.2 Subcutaneous Vaccine Adjuvants Upstream Analysis
        8.2.1 Subcutaneous Vaccine Adjuvants Core Raw Materials
        8.2.2 Main Manufacturers of Subcutaneous Vaccine Adjuvants Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Subcutaneous Vaccine Adjuvants Production Mode
    8.6 Subcutaneous Vaccine Adjuvants Procurement Model
    8.7 Subcutaneous Vaccine Adjuvants Industry Sales Model and Sales Channels
        8.7.1 Subcutaneous Vaccine Adjuvants Sales Model
        8.7.2 Subcutaneous Vaccine Adjuvants Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Subcutaneous Vaccine Adjuvants Production Value by Region (2019, 2023 and 2030) & (USD Million)
    Table 2. World Subcutaneous Vaccine Adjuvants Production Value by Region (2019-2024) & (USD Million)
    Table 3. World Subcutaneous Vaccine Adjuvants Production Value by Region (2025-2030) & (USD Million)
    Table 4. World Subcutaneous Vaccine Adjuvants Production Value Market Share by Region (2019-2024)
    Table 5. World Subcutaneous Vaccine Adjuvants Production Value Market Share by Region (2025-2030)
    Table 6. World Subcutaneous Vaccine Adjuvants Production by Region (2019-2024) & (K Units)
    Table 7. World Subcutaneous Vaccine Adjuvants Production by Region (2025-2030) & (K Units)
    Table 8. World Subcutaneous Vaccine Adjuvants Production Market Share by Region (2019-2024)
    Table 9. World Subcutaneous Vaccine Adjuvants Production Market Share by Region (2025-2030)
    Table 10. World Subcutaneous Vaccine Adjuvants Average Price by Region (2019-2024) & (US$/Unit)
    Table 11. World Subcutaneous Vaccine Adjuvants Average Price by Region (2025-2030) & (US$/Unit)
    Table 12. Subcutaneous Vaccine Adjuvants Major Market Trends
    Table 13. World Subcutaneous Vaccine Adjuvants Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
    Table 14. World Subcutaneous Vaccine Adjuvants Consumption by Region (2019-2024) & (K Units)
    Table 15. World Subcutaneous Vaccine Adjuvants Consumption Forecast by Region (2025-2030) & (K Units)
    Table 16. World Subcutaneous Vaccine Adjuvants Production Value by Manufacturer (2019-2024) & (USD Million)
    Table 17. Production Value Market Share of Key Subcutaneous Vaccine Adjuvants Producers in 2023
    Table 18. World Subcutaneous Vaccine Adjuvants Production by Manufacturer (2019-2024) & (K Units)
    Table 19. Production Market Share of Key Subcutaneous Vaccine Adjuvants Producers in 2023
    Table 20. World Subcutaneous Vaccine Adjuvants Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 21. Global Subcutaneous Vaccine Adjuvants Company Evaluation Quadrant
    Table 22. World Subcutaneous Vaccine Adjuvants Industry Rank of Major Manufacturers, Based on Production Value in 2023
    Table 23. Head Office and Subcutaneous Vaccine Adjuvants Production Site of Key Manufacturer
    Table 24. Subcutaneous Vaccine Adjuvants Market: Company Product Type Footprint
    Table 25. Subcutaneous Vaccine Adjuvants Market: Company Product Application Footprint
    Table 26. Subcutaneous Vaccine Adjuvants Competitive Factors
    Table 27. Subcutaneous Vaccine Adjuvants New Entrant and Capacity Expansion Plans
    Table 28. Subcutaneous Vaccine Adjuvants Mergers & Acquisitions Activity
    Table 29. United States VS China Subcutaneous Vaccine Adjuvants Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 30. United States VS China Subcutaneous Vaccine Adjuvants Production Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 31. United States VS China Subcutaneous Vaccine Adjuvants Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
    Table 32. United States Based Subcutaneous Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Subcutaneous Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
    Table 34. United States Based Manufacturers Subcutaneous Vaccine Adjuvants Production Value Market Share (2019-2024)
    Table 35. United States Based Manufacturers Subcutaneous Vaccine Adjuvants Production (2019-2024) & (K Units)
    Table 36. United States Based Manufacturers Subcutaneous Vaccine Adjuvants Production Market Share (2019-2024)
    Table 37. China Based Subcutaneous Vaccine Adjuvants Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Subcutaneous Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
    Table 39. China Based Manufacturers Subcutaneous Vaccine Adjuvants Production Value Market Share (2019-2024)
    Table 40. China Based Manufacturers Subcutaneous Vaccine Adjuvants Production (2019-2024) & (K Units)
    Table 41. China Based Manufacturers Subcutaneous Vaccine Adjuvants Production Market Share (2019-2024)
    Table 42. Rest of World Based Subcutaneous Vaccine Adjuvants Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Subcutaneous Vaccine Adjuvants Production Value, (2019-2024) & (USD Million)
    Table 44. Rest of World Based Manufacturers Subcutaneous Vaccine Adjuvants Production Value Market Share (2019-2024)
    Table 45. Rest of World Based Manufacturers Subcutaneous Vaccine Adjuvants Production (2019-2024) & (K Units)
    Table 46. Rest of World Based Manufacturers Subcutaneous Vaccine Adjuvants Production Market Share (2019-2024)
    Table 47. World Subcutaneous Vaccine Adjuvants Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 48. World Subcutaneous Vaccine Adjuvants Production by Type (2019-2024) & (K Units)
    Table 49. World Subcutaneous Vaccine Adjuvants Production by Type (2025-2030) & (K Units)
    Table 50. World Subcutaneous Vaccine Adjuvants Production Value by Type (2019-2024) & (USD Million)
    Table 51. World Subcutaneous Vaccine Adjuvants Production Value by Type (2025-2030) & (USD Million)
    Table 52. World Subcutaneous Vaccine Adjuvants Average Price by Type (2019-2024) & (US$/Unit)
    Table 53. World Subcutaneous Vaccine Adjuvants Average Price by Type (2025-2030) & (US$/Unit)
    Table 54. World Subcutaneous Vaccine Adjuvants Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 55. World Subcutaneous Vaccine Adjuvants Production by Application (2019-2024) & (K Units)
    Table 56. World Subcutaneous Vaccine Adjuvants Production by Application (2025-2030) & (K Units)
    Table 57. World Subcutaneous Vaccine Adjuvants Production Value by Application (2019-2024) & (USD Million)
    Table 58. World Subcutaneous Vaccine Adjuvants Production Value by Application (2025-2030) & (USD Million)
    Table 59. World Subcutaneous Vaccine Adjuvants Average Price by Application (2019-2024) & (US$/Unit)
    Table 60. World Subcutaneous Vaccine Adjuvants Average Price by Application (2025-2030) & (US$/Unit)
    Table 61. Agenus Basic Information, Manufacturing Base and Competitors
    Table 62. Agenus Major Business
    Table 63. Agenus Subcutaneous Vaccine Adjuvants Product and Services
    Table 64. Agenus Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 65. Agenus Recent Developments/Updates
    Table 66. Agenus Competitive Strengths & Weaknesses
    Table 67. Croda International Basic Information, Manufacturing Base and Competitors
    Table 68. Croda International Major Business
    Table 69. Croda International Subcutaneous Vaccine Adjuvants Product and Services
    Table 70. Croda International Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 71. Croda International Recent Developments/Updates
    Table 72. Croda International Competitive Strengths & Weaknesses
    Table 73. Seppic Basic Information, Manufacturing Base and Competitors
    Table 74. Seppic Major Business
    Table 75. Seppic Subcutaneous Vaccine Adjuvants Product and Services
    Table 76. Seppic Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 77. Seppic Recent Developments/Updates
    Table 78. Seppic Competitive Strengths & Weaknesses
    Table 79. OZ Biosciences Basic Information, Manufacturing Base and Competitors
    Table 80. OZ Biosciences Major Business
    Table 81. OZ Biosciences Subcutaneous Vaccine Adjuvants Product and Services
    Table 82. OZ Biosciences Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 83. OZ Biosciences Recent Developments/Updates
    Table 84. OZ Biosciences Competitive Strengths & Weaknesses
    Table 85. Phibro Animal Health Basic Information, Manufacturing Base and Competitors
    Table 86. Phibro Animal Health Major Business
    Table 87. Phibro Animal Health Subcutaneous Vaccine Adjuvants Product and Services
    Table 88. Phibro Animal Health Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 89. Phibro Animal Health Recent Developments/Updates
    Table 90. Phibro Animal Health Competitive Strengths & Weaknesses
    Table 91. Associated British Foods Basic Information, Manufacturing Base and Competitors
    Table 92. Associated British Foods Major Business
    Table 93. Associated British Foods Subcutaneous Vaccine Adjuvants Product and Services
    Table 94. Associated British Foods Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 95. Associated British Foods Recent Developments/Updates
    Table 96. Associated British Foods Competitive Strengths & Weaknesses
    Table 97. InvivoGen Basic Information, Manufacturing Base and Competitors
    Table 98. InvivoGen Major Business
    Table 99. InvivoGen Subcutaneous Vaccine Adjuvants Product and Services
    Table 100. InvivoGen Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 101. InvivoGen Recent Developments/Updates
    Table 102. InvivoGen Competitive Strengths & Weaknesses
    Table 103. Merck KGaA Basic Information, Manufacturing Base and Competitors
    Table 104. Merck KGaA Major Business
    Table 105. Merck KGaA Subcutaneous Vaccine Adjuvants Product and Services
    Table 106. Merck KGaA Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 107. Merck KGaA Recent Developments/Updates
    Table 108. Merck KGaA Competitive Strengths & Weaknesses
    Table 109. CSL Limited Basic Information, Manufacturing Base and Competitors
    Table 110. CSL Limited Major Business
    Table 111. CSL Limited Subcutaneous Vaccine Adjuvants Product and Services
    Table 112. CSL Limited Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 113. CSL Limited Recent Developments/Updates
    Table 114. CSL Limited Competitive Strengths & Weaknesses
    Table 115. GSK Basic Information, Manufacturing Base and Competitors
    Table 116. GSK Major Business
    Table 117. GSK Subcutaneous Vaccine Adjuvants Product and Services
    Table 118. GSK Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 119. GSK Recent Developments/Updates
    Table 120. GSK Competitive Strengths & Weaknesses
    Table 121. Dynavax Technologies Basic Information, Manufacturing Base and Competitors
    Table 122. Dynavax Technologies Major Business
    Table 123. Dynavax Technologies Subcutaneous Vaccine Adjuvants Product and Services
    Table 124. Dynavax Technologies Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 125. Dynavax Technologies Recent Developments/Updates
    Table 126. Novavax Basic Information, Manufacturing Base and Competitors
    Table 127. Novavax Major Business
    Table 128. Novavax Subcutaneous Vaccine Adjuvants Product and Services
    Table 129. Novavax Subcutaneous Vaccine Adjuvants Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
    Table 130. Global Key Players of Subcutaneous Vaccine Adjuvants Upstream (Raw Materials)
    Table 131. Subcutaneous Vaccine Adjuvants Typical Customers
    Table 132. Subcutaneous Vaccine Adjuvants Typical Distributors
List of Figure
    Figure 1. Subcutaneous Vaccine Adjuvants Picture
    Figure 2. World Subcutaneous Vaccine Adjuvants Production Value: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Subcutaneous Vaccine Adjuvants Production Value and Forecast (2019-2030) & (USD Million)
    Figure 4. World Subcutaneous Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 5. World Subcutaneous Vaccine Adjuvants Average Price (2019-2030) & (US$/Unit)
    Figure 6. World Subcutaneous Vaccine Adjuvants Production Value Market Share by Region (2019-2030)
    Figure 7. World Subcutaneous Vaccine Adjuvants Production Market Share by Region (2019-2030)
    Figure 8. North America Subcutaneous Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 9. Europe Subcutaneous Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 10. China Subcutaneous Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 11. Japan Subcutaneous Vaccine Adjuvants Production (2019-2030) & (K Units)
    Figure 12. Subcutaneous Vaccine Adjuvants Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Subcutaneous Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 15. World Subcutaneous Vaccine Adjuvants Consumption Market Share by Region (2019-2030)
    Figure 16. United States Subcutaneous Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 17. China Subcutaneous Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 18. Europe Subcutaneous Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 19. Japan Subcutaneous Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 20. South Korea Subcutaneous Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 21. ASEAN Subcutaneous Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 22. India Subcutaneous Vaccine Adjuvants Consumption (2019-2030) & (K Units)
    Figure 23. Producer Shipments of Subcutaneous Vaccine Adjuvants by Manufacturer Revenue ($MM) and Market Share (%): 2023
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Subcutaneous Vaccine Adjuvants Markets in 2023
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Subcutaneous Vaccine Adjuvants Markets in 2023
    Figure 26. United States VS China: Subcutaneous Vaccine Adjuvants Production Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 27. United States VS China: Subcutaneous Vaccine Adjuvants Production Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Subcutaneous Vaccine Adjuvants Consumption Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. United States Based Manufacturers Subcutaneous Vaccine Adjuvants Production Market Share 2023
    Figure 30. China Based Manufacturers Subcutaneous Vaccine Adjuvants Production Market Share 2023
    Figure 31. Rest of World Based Manufacturers Subcutaneous Vaccine Adjuvants Production Market Share 2023
    Figure 32. World Subcutaneous Vaccine Adjuvants Production Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 33. World Subcutaneous Vaccine Adjuvants Production Value Market Share by Type in 2023
    Figure 34. Infectious Diseases
    Figure 35. Cancer
    Figure 36. Others
    Figure 37. World Subcutaneous Vaccine Adjuvants Production Market Share by Type (2019-2030)
    Figure 38. World Subcutaneous Vaccine Adjuvants Production Value Market Share by Type (2019-2030)
    Figure 39. World Subcutaneous Vaccine Adjuvants Average Price by Type (2019-2030) & (US$/Unit)
    Figure 40. World Subcutaneous Vaccine Adjuvants Production Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 41. World Subcutaneous Vaccine Adjuvants Production Value Market Share by Application in 2023
    Figure 42. Research Applications
    Figure 43. Commercial Applications
    Figure 44. World Subcutaneous Vaccine Adjuvants Production Market Share by Application (2019-2030)
    Figure 45. World Subcutaneous Vaccine Adjuvants Production Value Market Share by Application (2019-2030)
    Figure 46. World Subcutaneous Vaccine Adjuvants Average Price by Application (2019-2030) & (US$/Unit)
    Figure 47. Subcutaneous Vaccine Adjuvants Industry Chain
    Figure 48. Subcutaneous Vaccine Adjuvants Procurement Model
    Figure 49. Subcutaneous Vaccine Adjuvants Sales Model
    Figure 50. Subcutaneous Vaccine Adjuvants Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Agenus
Croda International
Seppic
OZ Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
GSK
Dynavax Technologies
Novavax

Related Reports

Global Subcutaneous Vaccine Adjuvants Supply, Demand and Key Producers, 2023-2029

Global Subcutaneous Vaccine Adjuvants Supply, Demand and Key Producers, 2023-2029

date 04 Feb 2023

date Pharma & Healthcare

The global Subcutaneous Vaccine Adjuvants market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Subcutaneous Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Subcutaneous Vaccine Adjuvants Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Subcutaneous Vaccine Adjuvants market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Subcutaneous Vaccine Adjuvants

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>